Selling AI into Healthcare: What Makes Doctors Trust Your Product?
Your demo works. Your benchmarks look great. But will a doctor trust your AI with part of a patient’s care, and what happens if it gets something wrong?
Join Klaimee for a live conversation with Dr. Nakul Shekhawat, MD, MPH, eye surgeon and Visilant co-founder, on what healthcare AI vendors need to earn clinical trust and stand behind their products.
Built for founders and teams selling agentic software into healthcare, this webinar explores the questions behind adoption: evidence, real-world failure, responsibility, and what a meaningful product promise should look like.
What we’ll discuss
What a doctor needs to see before trusting an AI tool with part of a patient’s care. Is good performance enough, or does the plan for failure matter just as much?
How the possibility of errors affects willingness to adopt AI, and the concerns that come up in practice.
What clinicians expect an AI vendor to take responsibility for when its product makes a mistake, and where the clinician’s responsibility begins.
What “we stand behind our product” should actually mean, including concrete commitments when something goes wrong.
When founders should bring up risk and their response plan during a healthcare sales conversation.
Who should join
Founders, product leaders, and GTM teams building or selling AI agents into healthcare, from patient communications and care coordination to clinical and administrative workflows.
Come away with a clearer view of the trust questions your buyers may be asking, and how to address them in your product, sales conversations, and commitments to customers.
ABOUT THE SPEAKER
Dr. Nakul Shekhawat is a Johns Hopkins physician and eye surgeon who builds and deploys medical AI. He is co-founder and Chief Medical Officer of Visilant, which uses AI and telemedicine to bring eye screening to patients globally. His research at Johns Hopkins develops AI tools to diagnose and predict outcomes in eye disease. He works with medical AI and engineering teams on clinical validation, safety, and real-world deployment for AI and new medical technologies. He holds an endowed professorship at Johns Hopkins Medicine, an MD from Vanderbilt University, and an MPH and ScM from Johns Hopkins.
Hosted by Ines Boutemadja, co-founder and CEO of Klaimee.
Thursday, November 19, 2026 · 11:30 AM–12:15 PM PST Online webinar · Joining details will be shared with registered attendees.